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Age-Related Hearing Loss: Unraveling the Pieces
Nathan C. Tu, MD; Rick A. Friedman, MD, PhD
Age-related hearing loss (ARHL) is the most common cause of hearing loss in the world. The development of ARHL in
each individual is multifactorial, involving both intrinsic and extrinsic factors. This review highlights several of the key find-
ings in the ARHL literature and discusses future directions.
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INTRODUCTION
Age-related hearing loss (ARHL), or presbycusis, is
the most common cause of hearing loss and is one of the
most prevalent conditions affecting the elderly globally.
Estimates suggest approximately two-thirds of people
over the age of 70 in the United States experience
ARHL,1 and that by 2020, over half of all people in the
United States with hearing loss will be over 70 years of
age.2 ARHL has been shown to be independently associ-
ated with cognitive decline, dementia, depression, and
loneliness3–6 and results in an estimated annual economic
burden of over $3 billion in medical expenditures.7
Although the use of hearing aids and/or cochlear implants
has been shown to improve many of these associated con-
ditions,5,8,9 ARHL remains significantly undertreated.10,11
The development of ARHL is clearly multifactorial,
involving both intrinsic and extrinsic factors. Genetics
has been demonstrated to play a role, while environmen-
tal exposures accumulated throughout life are also
important influences on hearing in the elderly. The nat-
ural process of aging is associated with many changes in
the inner ear that have been noted in histologic studies,
yet not all elderly experience ARHL. Other comorbidities
may additionally influence the development or severity
of presbycusis. Consequently, research on the pathophys-
iology of ARHL has been challenging to synthesize in
light of these interactions. In this discussion, we aim to
highlight a few of the key findings in the ARHL litera-
ture and briefly discuss future directions.
Histopathology of ARHL
Schuknecht’s seminal studies correlating audiogram
findings in presbycusis with histopathologic findings in
human cochlea initially produced four categories of pres-
bycusis, which were later expanded to six: sensory, neural,
strial (metabolic), cochlear conductive, mixed, and inde-
terminate. Sensory presbycusis was described as abrupt
high-frequency hearing loss associated with atrophy of the
basal organ of Corti. Neural presbycusis exhibited dimin-
ished word discrimination scores and relatively stable
pure tone thresholds, with spiral ganglion cell loss. Strial,
or metabolic, presbycusis was characterized by overall
diminished pure tone thresholds in all frequencies, and
associated with stria vascularis atrophy. Cochlear conduc-
tive, or mechanical, presbycusis was described as having a
gradual down-sloping audiogram with no obvious histo-
logic findings, and hypothesized to be a result of basilar
membrane stiffening. Mixed presbycusis demonstrated a
combination of the previously described audiograms and
histologies, while indeterminate presbycusis (represent-
ing nearly 25% of all patients) did not demonstrate a con-
sistent histologic appearance while manifesting as either
flat or high-frequency loss.12–14
This classification system has served as a useful
framework to understand the various presentations of
presbycusis, although in reality there is almost certainly
significant overlap.15 The role of stria vascularis atrophy,
diminished Na1 K1 ATPase function, and its effects on
the endolymphatic potential (EP) have been studied and
found to factor prominently in the aging cochlea. The pri-
mary function of the stria vascularis is to maintain high
K1 concentration in the scala media, which contributes
heavily to generating the EP. As Schuknecht observed,
changes in the stria vascularis have been observed consis-
tently in a subset of human histopathologic studies,14
while animal studies, particularly in gerbils, have
extended this observation by demonstrating decreased
Na1 K1 ATPase function and EP16,17 associated with
aging. Mechanisms for this decline are not fully
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understood, but may be related to microvasculature
changes18,19 and oxidative stress.20
Cochlear synaptopathy
The pathophysiology of both age-related and noise-
induced hearing loss has also traditionally been thought
to be associated with primary degeneration of outer hair
cells, with secondary deafferentation-associated degenera-
tion of the spiral ganglion cells and nerve fibers.21,22 How-
ever, recent observations of neural degeneration in the
absence of hair cell injury have resulted in a paradigm
shift in the understanding of the mechanisms by which
presbycusis may develop. The work of Kujawa and Liber-
man in animal models using immunostaining have
revealed a loss of cochlear synapses, termed cochlear syn-
aptopathy, with delayed spiral ganglion cell degeneration
which occurs in the absence of hair cell loss.23–25 Similarly,
in preserved human temporal bones, it has been observed
that spiral ganglion cell counts decrease throughout life
despite normal hair cell populations,26 while cochlear dis-
section and immunostaining of fresh human temporal
bones less than 12 hours post-mortem suggest a role for
cochlear synaptopathy in the aging ear.27 While the mech-
anism of this injury is not fully understood, it has been
postulated that glutamate excitotoxicity resulting in
swelling of the nerve terminals may play a role,23,28 par-
ticularly in the setting of noise-induced hearing loss.
Early detection of cochlear synaptopathy has proven
to be difficult as standard audiometric testing involves
pure tone thresholds, which tend to reflect hair cell func-
tion and are relatively insensitive to neural injury.14
Given the current inability to directly measure cochlear
synaptopathy in vivo, efforts are currently underway to
assess alternative metrics which indirectly assess early
injury. Auditory brainstem response (ABR) is one tech-
nique which is currently under investigation, and there is
early evidence that diminished wave I amplitude with nor-
mal thresholds may be an indication of early cochlear syn-
aptopathy.23,25 Additionally, it has been noted that this
cochlear synaptopathy may preferentially affect acoustic
nerve fibers which have low spontaneous discharge rates,
a finding that may explain the poor hearing-in-noise per-
formance of patients with ARHL.25,29 As a result, hearing-
in-noise testing may also provide another diagnostic
modality by which early injury can be detected; unfortu-
nately, this cannot be tested in animal models. Finally,
electrocochleography has also been reported as a potential
tool by which cochlear synaptopathy may be detected in
early hearing loss. Those at higher risk for hearing loss
demonstrated an elevated SP/AP ratio, reflecting a selec-
tive neural injury which may represent cochlear synaptop-
athy, although this hypothesis is currently unable to be
validated.30
Oxidative stress
Oxidative damage from reactive oxygen species
(ROS) has been a frequent field of investigation for
many diseases. Mitochondria have been implicated as a
major source of ROS, which has led to a theory of aging
which is driven largely by mutations in mitochondrial
DNA resulting from accumulation of ROS over time.31
Given the high metabolic demands of the stria vascula-
ris, oxidative stress has long been considered a major
factor in the histopathologic changes noted previously.32
Accelerated hearing loss, stria vascularis atrophy and
spiral ganglion degeneration were noted in a transgenic
mouse model which had decreased expression of an
important antioxidant enzyme.33 In contrast, overexpres-
sion of the same enzyme did not demonstrate a protec-
tive effect on presbycusis,33 suggesting the presence of
other unmeasured influencing factors. Interestingly, in
another aging mouse model, an oxidative imbalance was
noted to be heavily concentrated in the hair cells and
spiral ganglion cells while sparing the stria vascularis,34
raising the possibility for a broader role for oxidative
stress involving “sensory” and “neural” causes of presby-
cusis in addition to the hypothesized effect on the stria
vascularis. In human studies, plasma levels of detectable
ROS have also been demonstrated to be positively asso-
ciated with increased pure tone thresholds.35
A recent report using a mouse model of presbycusis
has provided evidence for a protective effect of exercise,
possibly via an anti-inflammatory pathway.36 Animals
which exercised displayed delayed declines in certain hear-
ing thresholds, greater hair cell survival, and increased spi-
ral ganglion neuron density compared to controls.
Additionally, exercise was associated with greater number
of capillaries in the apical regions of the cochlea. Gene
expression studies demonstrated significant decreases in
expression of several inflammatory genes with exercise,
suggesting an important link between microvasculature
changes and chronic inflammation resulting in long-term
histologic changes.
An important epidemiologic observation has been
the significant impact of race on hearing outcomes and
its suggested connection to oxidative stress. It has con-
sistently been noted that the risk of presbycusis is
reduced in black individuals compared to white individu-
als,10 and recent analysis indicates that darker skin
color is positively associated with improved hearing,
independent of ethnicity.37 In mice studies comparing
albinos to otherwise identical pigmented counterparts, a
higher proportion of albinos demonstrated decreased EP
as well as reduced strial thickness.38 It is hypothesized
that melanin may act as a chelator of metals, ions, and
oxidative radicals, thereby reducing the accumulated
effects of oxidative stress that leads to ARHL.39
Genetics of ARHL
While environmental risk factors for hearing loss
(including but not limited to noise, chemical exposure,
tobacco, alcohol, ototoxic medications) have been well
studied,40 it has been more challenging to tease apart
the genetic influences on ARHL. Twin studies have esti-
mated a heritability of 40 to 47%,41,42 while the Fra-
mingham analysis estimated 31 to 38%,43 suggesting
that both genes and environment play important roles.
Not surprisingly, the influence of environment increases
with age as individuals are exposed to more external
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stimuli which may exacerbate the natural course of pres-
bycusis.41 This interaction of genetics and environmental
factors certainly complicates our ability to separate each
individual contributor to ARHL but remains an area of
significant interest.
As discussed previously, there has been significant
interest in the role of ROS in ARHL. Mitochondria are
the major source of ROS, and it has been postulated
that mitochondrial DNA mutations may hasten the oxi-
dative damage sustained by the cochlea. Several human
studies have attempted to investigate the association
between common mitochondrial mutations and ARHL.
The most common mitochondrial deletion, known as
mtDNA4977 or the common deletion (CD), has been
shown to be associated with hearing loss44–46 in human
temporal bone studies. Further quantification of CD has
suggested a correlation between levels of CD in the
cochlear tissue and severity of hearing loss,47 although
this finding was unable to be repeated in a separate
study.48 One of the genes located in the CD is the cyto-
chrome c oxidase subunit 3 (COX 3), a vital component
of the electron transport chain in mitochondria, and a
deficiency of COX3 has been noted in human temporal
bones of patients with presbycusis.49 Additionally, it has
also been observed that temporal bones of patients with
ARHL with the CD also demonstrate narrowed vascula-
ture, leading to the hypothesis that diminished vascular
supply to the inner ear may compound rates of mito-
chondrial mutation.46
In recent years, genome-wide association studies
(GWAS) have attempted to identify single nucleotide
polymorphisms (SNP) which may be associated with
ARHL, although given the polygenic nature of the condi-
tion, it has been difficult to consistently identify genes of
interest.50 One GWAS study in a European population of
834 cases and 834 controls identified significant variants
located in GRM7, a gene encoding a metabotropic gluta-
mate receptor which was found in spiral ganglion cells
as well as inner and outer hair cells.51 These variants
were later studied in a separate American population of
687 individuals of European descent and found to have
significant effects on pure tone thresholds as well as
speech reception thresholds, but not hearing-in-noise
testing.52 A separate GWAS of a genetically isolated
Finnish population similarly identified a significant SNP
directly downstream of the GRM7 locus.53 In light of the
recent findings of cochlear synaptopathy and the postu-
lated mechanism of glutamate toxicity, GRM7 may be of
particular interest for further study. The same study of
the Finnish population also identified a SNP involving
the gene encoding IQGAP2, a cochlear GTPase found to
play a role in cadherin-mediated adhesion. Given the
role of cadherins in maintaining hair cell function and
their implicated role in several syndromes characterized
by hearing loss,54 this may also be another promising
direction for future investigation.
Due to the complexity of ARHL, there has been
increasing interest in GWAS studies in the mouse model.
Compared to human studies, mouse studies have the
advantage of controlling for environmental exposure,
improved replicability, and greater genetic contribution to
hearing traits. The development of a population of mouse
strains designed for use in complex traits, referred to as
the Hybrid Mouse Diversity Panel (HMDP), has allowed
greater resolution of genetic mapping in the study of
ARHL.55,56 Baseline ABR threshold phenotypes of 100
HMDP strains have recently been reported in the litera-
ture57 and demonstrated substantial inter-strain variabil-
ity at each of six frequencies. GWAS performed on the
HMDP comparing strains for each of the six frequencies
demonstrated several significant loci, suggesting a role for
frequency-specific genetic contributions as well as loci
which contributed to hearing across all frequencies.58 A
new technique permitting meta-analysis of mouse GWAS
studies involving heterogeneous populations identified
several novel loci which previously were not recognized in
prior studies, as well as reconfirming several known loci
involved in ARHL.59 Additional studies involving the
HMDP are currently underway and are likely to continue
to identify loci of interest for future investigation. Contin-
ued improvements in the field of genomic studies carry
significant promise in revealing the genetic architecture
of ARHL and its interaction with the environment.
Future Directions
Traditionally, treatment options have been limited
to hearing aids and cochlear implantation. Recent find-
ings may open the door for new pathways for treatment,
particularly if earlier detection is possible. Given the
potential role of oxidative stress in ARHL, there has
been significant interest in clinical trials investigating
molecules which target oxidative stress pathways, sev-
eral of which are in Phase III trials.60 Lifestyle modifica-
tions may also have a role in delaying presbycusis. As
discussed previously, exercise has been shown to
improve both the histologic and functional findings of
hearing loss.36 Dietary supplementation of antioxidants
and vitamins have been studied in animal models of
ARHL with mixed results. While some have reported an
otoprotective benefit with vitamin E, vitamin C, and cal-
orie restriction,61 others have reported no differences in
either hearing outcomes or histopathology.62
Human studies of dietary influences on hearing out-
comes have similarly demonstrated mixed results, and are
additionally fraught with confounders. Antioxidants have
been shown to potentially be helpful in the setting of noise-
induced and drug-induced hearing loss, and response is
also much more easily assessed. However, in the setting of
presbycusis, there is no acute insult resulting in hearing
loss, making hearing outcomes of dietary supplementation
more challenging to assess. A cross-sectional study of
human adults correlating hearing and self-reported diet
suggested an association between higher carbohydrate,
vitamin C, vitamin E, riboflavin, magnesium, and lycopene
ingestion with lower pure-tone thresholds and larger optoa-
coustic emissions,63 while another cross-sectional investi-
gation of the relationship between hearing thresholds and
the Healthy Eating Index (an overall assessment of an indi-
vidual’s compliance with general dietary recommendations)
suggested that overall healthier eating was associated with
improved high-frequency thresholds.64 Further illustrating
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the complex interplay of factors influencing hearing, it was
demonstrated that individuals who had a significant noise
exposure history experienced a greater hearing benefit
from healthier eating than those without.64
The discovery of cochlear synaptopathy has prompted
investigation of a separate pathway of therapeutics. Neuro-
trophins which have demonstrated the ability to neuronal
survival and dendritic sprouting have been of particular
interest. In a guinea pig model of noise-induced hearing
loss, brain-derived neurotrophic factor and neurotrophin-3
were applied to the round window following significant
noise exposure. Those treated with neurotrophins were
found to exhibit reduced levels of cochlear synatopathy on
immunohistochemistry as well as preserved ABR, provid-
ing strong evidence for a protective role.65 Overexpression
of neutrophin-3 in a mouse model interestingly did not pre-
vent the occurrence of synapse loss immediately following
acoustic trauma, but did promote synapse recovery after
several weeks; in contrast, control animals demonstrated
progressive synapse loss.66 Similar studies in animal mod-
els of ARHL should be conducted to confirm benefit of these
neurotrophic factors.
CONCLUSION
ARHL is one of the most common conditions affecting
the elderly, and its incidence is projected to continue to
increase as the population ages. It represents a common
terminal condition with a multitude of both extrinsic and
intrinsic factors variably influencing each individual
throughout life. Recent findings have changed the under-
standing of the pathophysiology of ARHL and have forced
a reconsideration of the sequence of events by which hear-
ing loss in the elderly develops. Early detection and pre-
vention of ARHL may be the most successful therapeutic
strategy, and future research should focus on long-term
strategies by which this may be achieved.
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